Cytotoxicity and expansion of human tk+ mH antigen-specific CTLs after IL-7Rα sequential sorting
CTLs* . | IL-7Rα+,† % . | Sorting . | IL-7Rα+,† % . | Re-sorting . | ||||
---|---|---|---|---|---|---|---|---|
IL-7Rα,‡ % . | Cytotoxicity,§ % . | Expansion,¶ fold . | IL-7Rα,‡ % . | Cytotoxicity,§ % . | Expansion,¶ fold . | |||
HA1-tk #1 | 32.9 | 92.4pos | 12.7 | 17.6 | 12.6 | 95.3pos | 21.2 | 10.4 |
< 1neg | 65.7 | 4.1 | < 1neg | 78.5 | 4.7 | |||
HA1-tk #2 | 54.6 | 86.7pos | 16.8 | 24.2 | 10.9 | 91.7pos | 11.5 | 14.5 |
2.3neg | 54.2 | 4.6 | 1.8neg | 84.5 | — | |||
HY-tk #1 | 21.7 | 81.8pos | 21.2 | 35.1 | 15.4 | 89.6pos | 22.6 | 12.3 |
5.6neg | 74.0 | 8.7 | 1.5neg | 81.2 | 3.5 |
CTLs* . | IL-7Rα+,† % . | Sorting . | IL-7Rα+,† % . | Re-sorting . | ||||
---|---|---|---|---|---|---|---|---|
IL-7Rα,‡ % . | Cytotoxicity,§ % . | Expansion,¶ fold . | IL-7Rα,‡ % . | Cytotoxicity,§ % . | Expansion,¶ fold . | |||
HA1-tk #1 | 32.9 | 92.4pos | 12.7 | 17.6 | 12.6 | 95.3pos | 21.2 | 10.4 |
< 1neg | 65.7 | 4.1 | < 1neg | 78.5 | 4.7 | |||
HA1-tk #2 | 54.6 | 86.7pos | 16.8 | 24.2 | 10.9 | 91.7pos | 11.5 | 14.5 |
2.3neg | 54.2 | 4.6 | 1.8neg | 84.5 | — | |||
HY-tk #1 | 21.7 | 81.8pos | 21.2 | 35.1 | 15.4 | 89.6pos | 22.6 | 12.3 |
5.6neg | 74.0 | 8.7 | 1.5neg | 81.2 | 3.5 |
Thymidine kinase–positive CTLs used for sorting: HA1-tk #1, specific for HA-1 and induced from an HLA-A2pos/HA-1neg donor; HA1-tk #2, specific for HA-1 and induced from a second HLA-A2pos/HA-1neg donor; HY-tk #1, specific for H-Y and induced from an HLA-A2pos/H-Yneg (female) donor
Thymidine kinase–positive mH antigen-specific CTLs expressing IL-7Rα
Thymidine kinase–positive mH antigen-specific CTLs expressing IL-7Rα in the positive (pos) and in the negative (neg) fraction after IL-7Rα sorting
Cytotoxicity of IL-7Rα+ and IL-7Rα−tk+ mH antigen-specific CTLs against an LCL expressing the relevant mH antigen at a 20:1 ratio
Expansion of IL-7Rα+ and IL-7Rα−tk+ mH antigen-specific CTLs